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ABSTRACT 
Mathematical models that reflect the effects of dietary restriction (DR) on the sera 
metabolome may have utility in understanding the mechanisms of DR and in applying this 
knowledge to human epidemiological studies. Previous studies demonstrated both the feasi-
bility of identifying biomarkers through metabolome analysis and the validity of our ap-
proach in independent cohorts of 6-month-oId male and female ad libitum fed or DR rats. 
Cross-cohort studies showed that cohort-specific effects distorted the dataset The present 
study extends these observations across the entire sample set, thereby validating our mark-
ers independently of specific cohorts. Metabolites originally identified in males were exam-
ined in females and vice-versa. DR's effect on the m e t a b o l o m e is partially gender-specific 
and is modulated by environmental factors. DR reduces inter-gender differences in the 
metabolome. Univariate statistical methods showed that 56/93 metabolites in the female sam-
ples and 39/93 metabolites in the male samples were significantly altered (using our previ-
ous cut-off criteria of p ^ 0.2) by DR. The metabolites modulated by DR present a wide 
spectrum of concentration, redox reactivity and hydrophilicity, suggesting that our serotype 
is broadly representative of the metabolome and that DR has broad effects on the 
metabolome. These studies, coupled with those in the preceding and following reports, also 
highlight the utility for consideration of the metabolome as a network of metabolites using 
appropriate data analysis approaches. The inter-cohort and inter-gender differences ad-
dressed herein suggest potential cautions, and potential approaches, for identification of mul-
tivariate biomarker profiles that reflect changes in physiological status, such as a metabo-
lism that predisposes to increased risk of neoplasia. 
INTRODUCTION 
THE MAJOR IMPETUS for the investigation of dietary restriction (DR) \ n animal models stems from its fa-vorable modulation of a wide variety of physiologic as well as pathologic processes, including life-
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span and overall risk of certain cancers (Yu, 1994; Weindruch and Walford, 1988; Klurfield et al., 1987; 
Kritchevsky et al., 1984; Fernandes et al., 1995). The underlying effect of DR is thought to be attributable 
to a reduction in caloric intake as opposed to restriction of certain components in the diet (Iwasaki et al., 
1988; Kristal and Yu, 1994; Maeda et al., 1985; Shimokawa et al., 1996). This leads to a broad overview 
hypothesis that DR modulates metabolism, and that this modulation is reflected in the sera metabolome. 
Thus, we have proposed that the metabolome will reflect the altered metabolism that must be occurring in 
these animals (Shi et al., 2002b,c; Vigneau-Callahan et al., 2001). We are therefore taking a data-driven 
approach toward characterizing the metabolome, with an eye towards using this work in the future to iden-
tify biomarkers both for cancer risk in individuals as well as for better understanding of the epidemiologi-
cal relationships between caloric intake/balance and disease (Willett et al., 1999). 
Our studies have therefore been directed toward the identification of serum metabolite profiles reflective 
of the changes associated with DR. Inherent to studies of this nature is the production of large quantities 
of data requiring the use of powerful multivariate statistical methods for analysis (Eriksson et al., 2001; 
Kennedy et al., 1998; Manly, 2000). Studies concerned with multi- or megavariate data acquisition gener-
ate one of the resources necessary for building powerful models for sample categorization. While, ideally 
and in theory, all data in a study are derived exactly equally, this rarely, if ever, occurs in practice, as both 
biological and analytical confounds can hamper direct comparisons between datasets, even within a single 
laboratory or study. We begin to address these issues in our study in the current report. 
Our previous reports detailing the application of HPLC-based methods to measure low molecular weight 
redox-active metabolites in rodent sera have established both its feasibility and validity in determining pos-
sible serotypes indicative of the effects of DR (Shi et al., 2002b,c; Vigneau-Callahan et al., 2001; Shi et 
al., 2004). The present report seeks to continue this line of investigation by carrying out further analysis to 
maximize the number of useful metabolites while at the same time effectively eliminating any that are not 
informative or redundant. Related to this effort is the need to begin to compress inter-cohort variability (es-
sentially experimental noise) that would otherwise obscure the signal of interest (AL-DR differences in the 
metabolome). One aspect of this requirement is the need to generate normalized, cross-cohort datasets. This 
requirement is highlighted by the difficulties encountered by SIMCA (Soft Independent Modeling of Class 
Analogy, a specific pattern recognition approach) when working (training) on single cohort training sets, 
as described in the accompanying report (Shi et al., 2004). 
We further begin comparative analysis of how gender modulates the effects of DR on the metabolome. 
Despite the fact that the mechanisms of DR are not yet fully characterized, it is widely apparent that gen-
der can play a significant role with respect to the physiological effects of DR (Yu, 1994). Therefore, it is 
reasonable to conclude that whatever the mechanism of DR may be, gender-based variability must be ac-
counted for in order to fully comprehend its effects. 
MATERIALS AND METHODS 
Animal husbandry 
Details of the rats and animal husbandry conditions used in this study have been reported previously (Vig-
neau-Callahan et al., 2001). Briefly, male and female Fischer 344 x Brown Norway Fj rats were obtained 
monthly from the National Institute on Aging colony at Harlan (Indianapolis, IN) at 5 months of age and 
sacrificed approximately one month later. The basic animal husbandry for the animals used followed 
NLA/NIH guidelines as implemented by Harlan. Rats were fed NIH-3I (AL rats only) or vitamin-mineral 
fortified NIH-31 (DR rats only) (Vigneau-Callahan et al., 2001) for detailed diet compositions. All rats were 
individually housed and DR feeding regimens (40% less chow than eaten by AL rats) were implemented 
at 6 weeks of age. Animals were as follows: females (cohort A: 6 AL/6 DR rats; cohort B: 8 AL/7 DR rats; 
cohort C had 8 AL/8 DR rats); and males (cohort A: 8 AL/8 DR rats; cohort B: 7 AL/6 DR rats; cohort C: 
8 AL/6 DR rats). All animal experiments were performed under institutionally approved protocols and com-
plied with the Guide for Care and Use of Laboratory Animals. 
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HPLC methodology 
HPLC separations and coulometric array detection was conducted essentially as described previously, us-
ing ESA CoulArray system (ESA, Inc., Chelmsford, MA) (Kristal et al., 1998, 2002; Matson et al., 1984, 
1987; Shi et al., 2002a; Vigneau-Callahan et al., 2001). 
Statistical analysis 
Data analysis is described in the text. Data were analyzed using the programs CEAS 504 (ESA, Inc., 
Chelmsford, MA) and Statview 5.0.1 (SAS Institute, Cary, NC). 
RESULTS AND DISCUSSION 
In this report, we begin the process of making our sets of biomarkers more robust by conducting inter-
cohort and inter-gender comparisons. This analysis thus builds on our earlier reports, where we focused on 
analysis of intra-cohort and intra-gender data. 
These comparisons are expected to strengthen the overall profiles in several ways. Analysis of each orig-
inal sample with its opposite-gender serotype (cross-gender analysis) may potentially serve to increase the 
number of useful redox-active metabolites under investigation and contribute to the overall predictive value 
of the serotypes. Combination of the data obtained from each cohort will allow us to reduce chromatogram 
variability through normalization against serum tyrosine concentration. Identification of chromatogram peaks 
corresponding to back-waves will allow elimination of non-informative data. Subsequent application of uni-
variate statistical methods to the complete data set enables identification of metabolites that are potentially 
informative independent of cohort. Finally, we intend to apply principal component-based multivariate sta-
tistical methods on our data set in order to evaluate its potential use in the creation of a predictive model 
of DR. 
Initial cross-gender studies 
Integration and cross-comparisons of metabolites that comprise male and female serotypes allows iden-
tification of metabolites that may be useful in both genders. Initial analysis revealed twenty-five metabo-
lites that were considered important for discrimination of the DR serotype in both males and females. This 
comparison enables us to define three groups of metabolites: (A) those metabolities apparently altered only 
in females; (B) those metabolites apparently altered only in males, and; (C) those metabolites apparently 
altered in both genders. In practical terms, the fact that male and female samples hold certain informative 
metabolites in common results in a reduction in the analyte set under investigation, since the final number 
will be significantly less than the sum of the two original sets. That is to say, the original 63 metabolites 
of the female serotype and the original 66 metabolites of the male serotype (Shi et al., 2002a,b) yield a 
combined serotype of 104 metabolites. Moreover, computer-based peak identification and quantification as 
well as eventual manual verification of sample chromatograms will also be facilitated since one chro-
matogram standard containing female, male and male/female serotypes can be used for analysis. 
Cross-gender analysis additionally offers the potential to identify important metabolites that were missed 
in the first pass due to the analytical approaches taken for male and female samples (Shi et al., 2002b,c; 
Vigneau-Callahan et al., 2001). In theory, cross-gender analysis was to be conducted by direct quantitation, 
in all male samples, of those metabolites previously contained only in the female serotype, and, conversely, 
direct quantitation, in all female samples, of those metabolites previously contained only in the male serotype. 
In practice, we observed the requirement for intermediate steps. 
Metabolite hydrophobicity and electrochemical distribution 
Initial plots of previously identified metabolites across both retention time and electrochemical potential 
revealed two previously unappreciated aspects of our data (Fig. 1). It is apparent that the previously iden-
tified metabolites are widely distributed across both hydrophobicity (reflected in retention time) and elec-
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FIG. 1. Distribution of hydrophobicity and electrochemical reactivity of metabolites under investigation. The y-axis 
marks the dominant channel on which the particular metabolite gives most intense signal, while the x-axis marks the 
metabolite's retention time on that dominant channel. Solid circles represent metabolites that were originally defined 
in the male serotype, while empty circles represent metabolites that were originally defined in the female serotype. 
Overlapping points indicate metabolites shared by the two serotypes. 
trochemical potential (reflected in distribution across dominant channel). We also noted that some metabo-
lites contain multiple redox-active functional groups that display in a sample chromatogram as a primary 
wave in its low potential dominant and subdominant channels accompanied by its associated back-wave(s) 
in successive higher potential channels. In theory, back-waves are peaks from compounds that exhibit two 
or more oxidation events in the array because of their electrochemical properties and should reflect similar 
information about the variation of metabolite concentration as the primary wave. Treatment of back-waves 
was not a priority in previous studies, which were intrinsically driven by the desire to find peaks with util-
ity in defining class membership. Backwaves are now addressed and, where appropriate, eliminated, to re-
duce the number of non-informative metabolites present in the combined serotype. 
Elimination of redundant information contained in back-waves compresses the data set by decreasing the 
overall number of metabolites under investigation. This compression prevents multiple utilization of the 
same metabolite with subsequent over-weighting of the information contained therein. Primary waves and 
their accompanying back-waves were initially identified by visual inspection of the peaks contained in the 
standard chromatogram used for metabolite quantification. Subsequent verification consisted in the deter-
mination of the correlation coefficient (r) of the primary wave and its suspected back-wave in order to de-
termine the correlation between each. In the case of multiple suspected back-waves, r2 values were calcu-
lated for all possible pairings of primary and back-waves, with subsequent evaluation of the correlation 
between the primary wave and the mean of all the waves (Fig. 2). 
In the example presented in Figure 2, we observed a likely primary wave with a retention time of 6.408 
min, and its suspected back-waves at 6.425 and 6.467 min, respectively. The fact that the pairings shown 
have such high r 2 values demonstrates the validity of the theory that the information contained in the back-
waves can be represented by the primary wave alone. This analysis has permitted pruning of the compo-
nents of the combined metabolite serotype by 11 to a total of 93 while minimizing any loss of potential 
predictive value. 
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FIG. 2. Example of back-wave elimination. Panels a, b, and c depict calculation of the r 2 values of all possible pair-
ings of the primary wave with a retention time of 6.408 min (on its dominant channel) and its suspected back-waves 
at 6.425 and 6.467 min, respectively. Graph d depicts the calculation of the r 2 value of the primary wave and the mean 
value of all three waves. The strong correlation between all possible pairings indicates that no loss of information will 
accompany elimination of peaks representing metabolites that are back-waves of other metabolites. 
Metabolites were found to be broadly representative of a range of both concentrations (Fig. 3) as well as 
hydrophilicities and redox potentials (Fig. 1). The abscissa of Figure 3 represents the logarithm of the raw 
score of current (proportional to concentration) that each metabolite produces on its dominant channel in 
the chromatogram standard while the ordinate represents the number of metabolites with a current of that 
order of magnitude. Although the majority of metabolite peaks produce currents in the range of thousands 
and tens of thousands of instrument counts (arbitrary units), the peaks represent a fairly wide range of con-
centrations (~33,000-fold difference between the lowest and highest values). 
Cross-cohort normalization 
Normalization of quantified metabolite values based on tyrosine concentration in the serum reduces the 
coefficient of variation across studies. A second issue arising as we began to compare cohorts was the need 
to normalize our data between cohorts. Indeed, we determined that a major obstacle to successful integra-
tion of cross-cohort data is the diet-independent variability that exists between them (apparently largely bi-
ological variability) (Vigneau-Callahan et al., 2001). This effectively requires the identification of a marker 
that is itself independent of DR in order to normalize the data set. Measurement and subsequent statistical 
analysis with a two-tailed, unpaired /-test of tyrosine concentrations of all the samples in the data set allowed 
for the determination that tyrosine concentration is not significantly altered by DR. Therefore, quantitation 
of tyrosine may potentially serve to normalize the concentrations of all metabolites in a given sample. 
For normalization purposes, the mean of the tyrosine concentration of each sample in the initial training 
set was used as the factor to which each individual sample's tyrosine concentration was normalized. This 
ratio was multiplied by each metabolite's concentration to arrive at a normalized value for that metabolite. 
Subsequently, the effect of tyrosine normalization was evaluated by documenting any changes in the mean 
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FIG. 3. Biomarker concentrations in sera. The histogram shows percent of total markers broken down by the log of 
their total current reactivity (a marker of concentration). The biomarker concentrations tend toward a normal distribu-
tion, indicating that they may serve as a useful representation of serum metabolites in their entirety. 
coefficient of variation of analyte sets sorted either by gender, diet or cohort (Fig. 4). Each column pah-
shows the coefficients of variation of the entire data set sorted according to a different grouping variable 
(cohort, gender, or diet). For example, the coefficient of variation was calculated for each metabolite un-
der investigation in the pair labeled "cohort" after sorting the data set according to cohort of origin (i.e., A, 
B or C), exclusive of diet or gender. The coefficient of variation of each metabolite was averaged and the 
averages obtained from the normalized and non-normalized data were compared to determine whether ty-
rosine normalization reduced variation between cohorts, between genders, or between diets. 
The results seem to confirm that normalization to tyrosine concentration will reduce the inter-cohort vari-
ability of the sample data set while exerting a nominal effect on the gender and dietary variability. 
Cross-gender studies II. The data analysis presented above has simplified subsequent analyses by re-
ducing both the number of metabolites under study and by removing some of their intrinsic variability. We 
now reinitiate studies of the DR metabolome by initially examining univariate statistics. Univariate statis-
tical analysis of the normalized data set identifies metabolites that are significantly altered by DR. Subse-
quent to same-gender and cross-gender analysis as well as normalization, our working data set contained 
values for every metabolite under investigation in both male and female samples, irrespective of the serotype 
in which the metabolite was originally defined. We used two-tailed, unpaired /-tests on each metabolite in 
our completed data set to evaluate possible significant changes in sera concentration in the DR samples 
with respect to the AL samples. The p-values obtained from the /-tests are presented in Table 1. Our re-
sults indicate that out of a possible 93 metabolites under investigation, DR significantly altered the con-
centration of 56 of these in females and 39 in males. This is based on the initial criteria used to minimize 
Type II statistical errors, p < 0.2 (Shi et al., 2002b,c). 
Cross-gender comparison did serve to identify additional useful metabolites that had been missed previ-
ously. Following backwave removal, the female serotype contained 56 metabolites, 31 of which were thought 
to be of use exclusively in female samples. Statistical analysis of these 31 metabolites in the female sam-
ples demonstrated that 18 had a p < 0.2 between AL and DR (Table 1, data column 2). Additionally, nine 
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unnormalized 
normalized 
cohort g e n d e r diet 
F I G . 4 . Normalization against tyrosine corrects inter-cohort differences without altering other differences. These data 
illustrate the effect that tyrosine-based normalization has on the coefficient of variation of our dataset sorted by cohort, 
gender or diet. There is a marked reduction in variation between cohorts, while a nominal increase is demonstrated be-
tween both gender and diet. Note that this normalization reduces inter-cohort variability to a level comparable to that 
observed between both gender and diet 
of these 31 metabolites were significantly altered in the male samples after DR (Table 1, data column 4 ) . 
Following backwave removal, the male serotype contained 62 metabolites, 37 of which were thought to be 
of use exclusively in male samples. Statistical analysis of these 37 metabolites in the male and female sam-
ples demonstrated both contained a total of 18 that had a p < 0.2 between AL and DR (Table 1, data columns 
2 and 5). The female and male serotype shared 25 common metabolites. Statistical analysis of these 25 in 
female samples found 21 that were significantly altered by DR, while in the male samples only 12 were 
significantly altered (Table 1, data columns 3 and 6). 
TABLE 1. METABOLITES ORIGINALLY IDENTIFIED AS PART OF THE FEMALE OR MALE SEROTYPES ( 3 1 , 3 7 
METABOLITES, RESPECTIVELY) OR BOTH (25 METABOLITES) WERE SCORED IN MALE AND FEMALE SAMPLES 
Ad libitum/diet-restricted p values 
p 
Female samples Male samples 
F sew M sero M,F sero F sero M sero M,Fsero 
0.01 12 10 18 0 2 1 
0.05 2 2 0 2 5 3 
0.1 3 1 2 1 5 5 
0.2 0 5 1 6 6 3 
0.5 4 13 1 8 1 1 5 
1.0 10 6 3 14 8 8 
DR significantly altered 56/93 tested metabolites in females and 39/93 in males based on the initial criteria used to 
minimize Type II statistical errors, p < 0.2. 
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These cross-gender studies also pointed out the complex interactions between gender and diet with re-
spect to the metabolome. The data in Table 1 highlights the extent to which elements of our profile ap-
peared more likely to be truly different (specifically, lower p values) between AL and DR females than be-
tween AL and DR males. Both this greater abundance and the relative mean differences across those peaks 
differing at p < 0.2 are shown in Figure 1 (top two graphs, mean ± SEM, listed by, but not scaled to, re-
tention time). Note that this graph also reveals an interesting difference between the effects of DR on males 
and females. Those metabolites that differ between females on the different diets are almost always present 
in lower concentration in the DR than the AL rats (51/56), whereas this ratio is nearly neutral in males 
(20/37). The number of metabolites that differ between males and females were found to be greater in AL 
than DR rats (60/93 vs. 48/93, the bottom two panels in Figure 5, comparing analytes at p < 0.2, 41/93, 
vs. 15 over 93 at p S 0.01). This graph also reveals an interesting difference between the effects of DR on 
those metabolites that differ between the sexes. Those peaks that differ between males and females on the 
AL diets are almost always present in higher concentrations in the female rats (56/60), whereas this ratio 
is neary neutral in the DR rats (26/48). These differences are presented by p value in Figure 6. 
These data reveal that it will be necessary to build independent mathematical models to reflect the 
serotypes (metabolomes) of males and females subjected to DR. 
General implications for metabolomic studies. The work presented in this report addresses three areas of 
our study that are of general interest in the study of metabolome-nutrition interactions. These questions all 
center around the conversion from single cohort datasets to datasets that can address questions across the 
entire populations that we study. These areas may be summarized as analytical concerns, gender-specific 
metabolic profiles, and the requirement for examination of profiles vs single metabolites. 
The first area concerns the analytical issues involved in conducting a high data density study of samples 
that are collected over time for study of interactions between nutrition and the metabolome. As seen in this 
report, the practice of validating multiple independent sets of metabolites, initially described in previous 
papers (Vigneau-Callahan et al., 2001; Shi et al., 2002b,c), increases the yield of informative metabolites 
without increasing noise to levels that impair analysis. Our analysis also identified the importance of find-
ing a metabolite/variable that can function for normalization. Surprisingly, this task was relatively complex, 
as the concentration of most metabolites examined varyed significantly across different cohorts. Fortunately, 
tyrosine appeared to serve well as a normalizing agent Third, our work suggests that any study of the in-
teraction between nutrition and the metabolome must consider a deliberate multicohort design to avoid bi-
ases introduced by the use of a single cohort. 
The second area concerns the comparative effects of DR on males and females. Although gender-spe-
cific effects in DR are well-established, the major effects of DR—such as increased longevity and decreased 
morbidity—are highly consistent between males and females (in most strains). This leads to a straight-for-
ward hypothesis to be tested: DR modulates the metabolome of male and female animals equivalently. 
Other, weaker hypotheses that can be addressed in this area are that most metabolites will be well-con-
served, the general trends will be well-conserved, and that the major changes will be we 11-conserved be-
tween genders. The data presented in this paper argue against each of these, suggesting that the metabolome 
undergoes fundamentally gender-specific changes, with comparatively few gender-independent changes. In 
the accompanying paper (Paolucci et al., 2004) we will test a related hypothesis—whether classification 
based approaches can separate male and female AL and DR simultaneously. 
The third area concerns the power and utility of megavariate-based analysis for the study of metabolome-
nutrient interactions. This utility is reflected in two complementary ways. First, less than half of the ana-
lytes that comprise our serotypes would be considered to vary significantly between groups by classical cri-
teria (p < 0.05). Furthermore, many of those that do meet these criteria would not have been identified if 
we had not been able to work with the weaker criteria initially established (p < 0.2). The use of multi-/ 
mega-variate approaches (HCA, PCA) enabled us to identify profiles that worked, and carry the analytes 
that comprised them forward, with minimal concern about false positives. Thus, we have essentially iden-
tified a tool that considerably increases the statistical power of metabolomics studies. Second, even those 
metabolites that display statistically significant differences show considerable overlap between the two 
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FIG. 5. Gender-diet interactions—metabolite concentrations relative to pools. The mean ± sem (as percent of the 
standard pool) for all metabolites with p values of <0.2 between AL and DR female rats (top); AL and DR male rats 
(2 n d down); male and female AL rats (3 r d down); and male and female DR rats (bottom). Retention time is used as 
qualitative label rather than as a continuous quantitative variable to more clearly present mean ± SEM. 
groups. Thus, univariate statistical approaches in this system (AL-DR) do not identify class distinguishing 
elements (sometimes termed state-markers—markers whose presence or absence essentially defines the ex-
istence of a condition), while megavariate based approaches readily do so. From a conceptual viewpoint, 
this may be considered in following way: Visual inspection of the data in Figure 5 suggests an obvious pat-
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FIG. 6. Gender-diet interactions—p value distributions. Metabolites in the profile are plotted by: p values between 
AL and DR in males versus females (top); p values between males and females in AL and DR (bottom). Each plot is 
divided into four quadrants by the intersection of lines drawn at p = 0.2 on each axis. 
tern difference between AL and DR—but in large part this is obvious because humans recognize patterns 
so well. Mathematical identification, validation, and re-recognition of this pattern is often difficult, but we 
have accomplished this goal, as described in the previous and subsequent reports (Vigneau-Callahan et al., 
2001; Shi et al., 2002b,c, 2004; Paolucci et al., 2004). 
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CONCLUSION 
This report furthers our attempts to generate potential biomarkers of DR by integrating the data across 
cohorts and by conducting cross-gender comparisons. Tyrosine-based normalization of the data set has per-
mitted corrective scaling of our raw sample scores in order to compensate for potential variability in indi-
vidual chromatogram peak intensities. Elimination of back-waves was the final step in reducing the size 
of our data set before applying statistical analysis for validation across cohorts. Conducting cross-gender 
studies revealed a set of metabolites that had been identified in only one gender previously, but which in-
deed do differ statistically in both genders. Thus, overall, 56 and 39 of 93 variables differ at our cutoff of 
p < 0.2 in females and males, respectively. We further show that DR appears to have greater effects on the 
metabolome in females as compared to that of males, and that DR appears to reduce inter-gender differ-
ences in the metabolome. Most importantly, the analyses presented compress our six previous datasets (three 
cohorts each of females and males with 63 and 66 variables, respectively) into a single, 93 variable dataset 
by collapsing cohort distinctions, eliminating redundancy, and eliminating backwaves. These data are now 
in an appropriate form to allow us to begin to build more powerful mathematical class descriptors and class 
predictors. These data also present a univariate approach toward pruning this dataset, which will be com-
pared with that derived from multivariate analysis (Paolucci et al., 2004). 
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